Competition

  • February 18, 2026

    Judge Won't Let MediaTek Out Of Bogus Litigation Case

    A California federal judge won't grant Taiwanese semiconductor maker MediaTek Inc. a win in a lawsuit from Taiwanese competitor Realtek accusing the former of colluding with other companies to harass Realtek with bogus patent cases, saying a Texas federal judge's ruling that denied Realtek sanctions in a case there didn't mean the baselessness of the case couldn't be relitigated.

  • February 18, 2026

    Sandoz's Case Against Amgen Over Enbrel Biosimilar Tossed

    A Virginia federal court found that Sandoz Inc. should have brought its claims accusing Amgen of blocking competition for Enbrel in a previous patent dispute over the blockbuster autoimmune disease treatment.

  • February 18, 2026

    Sen. IP Leads Worry About Outsize Standards Influencers

    U.S. senators who lead the Judiciary Committee's subcommittee on intellectual property wrote to the head of the American National Standards Institute stressing "the essential importance of integrity, balance and transparency" while developing standards in the U.S.

  • February 18, 2026

    DOJ Allowed To Dictate Pay, Term Of Google Search Watchers

    A D.C. federal judge sided with the U.S. Department of Justice on Tuesday regarding the key terms of service for the five-member technical committee tasked with observing Google's compliance with mandates to prop up rival search engines with search results and data.

  • February 18, 2026

    Will Jurors Penalize AI? Study Examines Trade Secrets Impact

    A forthcoming academic study suggests juries may treat AI-enabled actions more harshly than human conduct in trade secrets disputes, resulting in what the authors call an “AI penalty.” Attorneys say reality is more complicated.

  • February 18, 2026

    Judge Rejects FTC's Emergency Bid To Spare Merger Rule

    The Federal Trade Commission has just until Thursday to obtain Fifth Circuit intervention after a Texas federal judge refused Wednesday to extend his seven-day pause on the order scrapping the agency's premerger reporting overhaul.

  • February 18, 2026

    J&J Unit Appeals $442M Catheter Antitrust Loss To 9th Circ.

    Johnson & Johnson's Biosense Webster health tech unit urged the Ninth Circuit to overturn a California federal jury's $147 million antitrust verdict — later upped to $442 million — over the company withholding cardiac mapping support to hospitals using third-party reprocessed catheters, saying Innovative Health LLC didn't prove its allegations of unlawful tying.

  • February 18, 2026

    Amazon Rips FTC's 'Farfetched' Antitrust Discovery Refusals

    Amazon slammed the Federal Trade Commission on Tuesday for treating discovery "as a one-way road" in the agency's antitrust case against the e-commerce giant, calling on a Seattle federal judge to again order the agency to cough up answers that the company says are key to formulating its defense.

  • February 18, 2026

    College Pitcher Drops NCAA Eligibility Suit After Early Blow

    A college baseball player hoping to pitch at Pepperdine University has dropped his suit against the NCAA's eligibility rules just days after a California federal judge rebuffed his bid to play while the lawsuit moved forward.

  • February 18, 2026

    Crowell & Moring Antitrust Leader Jumps To Sidley In NY

    Sidley Austin LLP said Wednesday it had hired the chair of Crowell & Moring LLP's New York antitrust practice.

  • February 18, 2026

    BlueScope Gets $11B 'Final' Bid From SGH, Steel Dynamics

    Australia's BlueScope Steel Ltd. said Wednesday it is reviewing a revised, unsolicited buyout bid from SGH Ltd. and Steel Dynamics Inc. worth $11 billion. 

  • February 18, 2026

    5 Firms Shape Kennedy Wilson's $1.65B Take-Private Deal

    Real estate investment firm Kennedy Wilson has announced it agreed to be taken private by a consortium led by the company's CEO and Canadian insurance company Fairfax Holdings in an up to $1.65 billion deal advised by five law firms.

  • February 18, 2026

    Visa, Mastercard Can't Avoid Swipe Fee Claims Pass-On

    Mastercard and Visa lost a bid on Wednesday to fend off a class action from retailers over unlawful card payment fees by arguing that the merchants didn't suffer loss because they passed on the charges.

  • February 18, 2026

    UK Consumer Group Drops £480M Qualcomm Class Action

    Consumer group Which has said it is dropping its £480 million ($651 million) collective action accusing Qualcomm of anticompetitive behavior that drove up the prices of Apple and Samsung phones before the result of a five-week trial is delivered.

  • February 17, 2026

    Dismissal Of FTC Merger Rule Shows Nothing 'Broken' To 'Fix'

    Some antitrust practitioners see vindication in last week's Texas federal court decision throwing out the Federal Trade Commission's premerger reporting overhaul, saying it gives credence to arguments that U.S. antitrust enforcers were trying to plug holes in merger review where there were none.

  • February 17, 2026

    States Hit Discovery Roadblocks In HPE Merger Fight With DOJ

    A California federal judge mostly sided with the Justice Department on Tuesday on the latest discovery disputes in state attorneys general's challenge to a DOJ settlement greenlighting Hewlett Packard Enterprise's $14 billion Juniper acquisition, ruling that HPE doesn’t need to reveal who's bidding for divested assets, and refusing to delay deadlines.

  • February 17, 2026

    Betting Tech Rivals Settle Antitrust, Patent Row

    Sports technology company Panda Interactive has settled its patent dispute with its rival Sportradar and asked a Texas federal judge to stay all activity in the case for 30 days while the parties finalize the agreement.

  • February 17, 2026

    Judge Rips Drugmakers' Borderline 'Disingenuous' Appeal Bid

    A Connecticut federal judge has rejected generic-drug makers' request for a quick appeal of his ruling denying them summary judgment on states' claims they engaged in an "overarching conspiracy" to fix prices, slamming the request for being borderline "disingenuous," mischaracterizing his reasoning and ignoring direct evidence of alleged wrongdoing.

  • February 17, 2026

    Union Says Express Scripts Diverted Billions In Kickback Fees

    A Chicago plumbers union healthcare fund told an Illinois federal court Tuesday that the nation's largest pharmacy benefit manager, Express Scripts, violated federal criminal law when it used a Switzerland-based company to hide kickbacks it generated by charging drug companies fees for key placement on prescription plan drug lists.  

  • February 17, 2026

    Pepsi And Walmart Inflated Soda Prices, ND Businesses Say

    Pepsi and Walmart devised a plan to inflate prices for Pepsi soft drinks above competitive levels, two North Dakota businesses said in a proposed class action in New York federal court that alleges the companies violated federal antitrust laws.

  • February 17, 2026

    CoStar Rival Urges High Court To Reject Antitrust Appeal

    A rival accusing CoStar of blocking competition for commercial real estate listing services is urging the U.S. Supreme Court not to review a ruling that revived the rival's counterclaims, saying that CoStar just disagrees with how the appeals court viewed the allegations.

  • February 17, 2026

    Sens. Concerned About Live Nation Case After DOJ 'Ousting'

    A group of Senate Democrats is raising concerns about potential political influence at the U.S. Department of Justice, following the abrupt departure of the agency's top antitrust enforcer weeks before Live Nation is set to face trial in the government's monopolization case.

  • February 17, 2026

    Battery Co. Calls Energizer's Trade Secret Claims 'Meritless'

    A California battery company accusing Energizer and Walmart of colluding to fix retail battery prices said Energizer's counterclaims of inducing an account manager to steal trade secrets were "tactical and meritless" and has asked a federal judge to dismiss them.

  • February 17, 2026

    Warner Bros. Rejects Latest Paramount Bid But Talks Resume

    Warner Bros. Discovery said Tuesday it has rejected an acquisition proposal from Paramount Skydance but will engage in further talks to determine whether the bidder can submit a binding offer that tops WBD's agreed merger with Netflix.

  • February 17, 2026

    Edwards Drops 'Anti-Copycatting' Policy Amid Antitrust Probe

    Edwards has dropped its policy of shunning clinicians and distributors who supported "copycat" medical device makers, heading off an investigation into whether the medical devices manufacturer might have breached European Union competition rules.

Expert Analysis

  • Lessons From 7th Circ.'s Deleted Chat Sanctions Ruling

    Author Photo

    The Seventh Circuit’s recent decision in Pable v. Chicago Transit Authority, affirming the dismissal of an ex-employee’s retaliation claims, highlights the importance of properly handling the preservation of ephemeral messages and clarifies key sanctions issues, says Philip Favro at Favro Law.

  • Opinion

    Sometimes Int'l Competition Should Trump Antitrust Concerns

    Author Photo

    The U.S. Justice Department's approval of HPE's $14 billion acquisition of Juniper Networks shows that a merger that significantly enhances innovation and competitiveness may serve consumer and national interests despite marginally increasing industry concentration, says John Reeves at Reeves Law.

  • Series

    Quilting Makes Me A Better Lawyer

    Author Photo

    Turning intricate patterns of fabric and thread into quilts has taught me that craftsmanship, creative problem-solving and dedication to incremental progress are essential to creating something lasting that will help another person — just like in law, says Veronica McMillan at Kramon & Graham.

  • A Look At Robinson-Patman Enforcement In The MLM Industry

    Author Photo

    The Federal Trade Commission's recent focus on price discrimination in high-profile speeches and litigation suggests a renewed interest around Robinson-Patman Act enforcement, particularly in multilevel marketing, making it an apt time for direct sellers to audit their pricing, say Katrina Eash at Winston & Strawn and Juliet Belling Warren and Branko Jovanovic at Edgeworth Economics.

  • What 2 Profs Noticed As Transactional Law Students Used AI

    Author Photo

    After a semester using generative artificial intelligence tools with students in an entrepreneurship law clinic, we came away with numerous observations about the opportunities and challenges such tools present to new transactional lawyers, say professors at Cornell Law School.

  • State AGs Are Turning Up The Antitrust Heat On ESG Actions

    Author Photo

    Recent antitrust developments from red state attorneys general continue a trend of environmental, social and governance scrutiny, and businesses exposed to these areas should conduct close examinations of strategy and potential material risk, say attorneys at Morgan Lewis.

  • Rebuttal

    BigLaw Settlements Should Not Spur Ethics Deregulation

    Author Photo

    A recent Law360 op-ed argued that loosening law firm funding restrictions would make BigLaw firms less inclined to settle with the Trump administration, but deregulating legal financing ethics may well prove to be not merely ineffective, but counterproductive, says Laurel Kilgour at the American Economic Liberties Project.

  • Opinion

    8th Circ. Should Reaffirm False Commercial Speech's Nature

    Author Photo

    The Eighth Circuit in Goldfinch Laboratory v. Iowa Pathology Associates should assert that false commercial speech is not categorically immune from antitrust scrutiny, says Daniel Graulich at the Federal Trade Commission.

  • How Big Pharma Has Responded To FTC Delisting Demands

    Author Photo

    Looking at some statistics concerning how pharmaceutical companies have responded to the Federal Trade Commission's recent challenges to Orange Book listings raises several possible hypotheses about the FTC's strategy and effectiveness, say Ratib Ali and Celia Lu at Competition Dynamics.

  • Unpacking Ore. Law's Limits On PE Healthcare Investment

    Author Photo

    A recent Oregon law imposes significant restrictions on nonphysicians owning or controlling medical practices, but newly enacted amendments provide some additional flexibility in certain ownership arrangements without scuttling the law's intent of addressing concerns about the rise of private equity investment in healthcare, say attorneys at Debevoise.

  • 5 Ways Lawyers Can Earn Back The Public's Trust

    Author Photo

    Amid salacious headlines about lawyers behaving badly and recent polls showing the public’s increasingly unfavorable view of attorneys, we must make meaningful changes to our culture to rebuild trust in the legal system, says Carl Taylor at Carl Taylor Law.

  • Class Actions At The Circuit Courts: August Lessons

    Author Photo

    In this month's review of class action appeals, Mitchell Engel at Shook Hardy discusses key takeaways from federal appellate decisions involving topics including antitrust, immigration, consumer fraud, birthright citizenship under the Fourteenth Amendment, and product defects.

  • Series

    Hiking Makes Me A Better Lawyer

    Author Photo

    On the trail, I have thought often about the parallels between hiking and high-stakes patent litigation, and why strategizing, preparation, perseverance and joy are important skills for success in both endeavors, says Barbara Fiacco at Foley Hoag.

  • Series

    Law School's Missed Lessons: Negotiation Skills

    Author Photo

    I took one negotiation course in law school, but most of the techniques I rely on today I learned in practice, where I've discovered that the process is less about tricks or tactics, and more about clarity, preparation and communication, says Grant Schrantz at Haug Barron.

  • DOJ Whistleblower Program May Fuel Criminal Antitrust Tack

    Author Photo

    A recently launched Justice Department program that provides rewards for reporting antitrust crimes related to the U.S. Postal Service will serve to supplement the department’s leniency program, signaling an ambition to expand criminal enforcement while deepening collaboration across agencies, say attorneys at Crowell & Moring.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.